Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, May 23, 2017

Public edition |

Newswise Cancer Research Wire for 23-May-2017

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

New Report: Just One Alcoholic Drink a Day Increases Breast Cancer Risk, Exercise Lowers Risk

Drinking just one glass of wine or other alcoholic drink a day increases breast cancer risk, finds a major new report by the American Institute for Cancer Research (AICR) and the World Cancer Research Fund (WCRF).

– Fred Hutchinson Cancer Research Center

Embargo expired on 23-May-2017 at 00:05 ET

Immunotherapy Data from the Cancer Research Institute Clinical Accelerator to Be Presented at ASCO Annual Meeting

data from four early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago on June 5, 2017.

– Cancer Research Institute

Study Leads to Breakthrough in Better Understanding Acute Myeloid Leukaemia

A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.

– University of Birmingham

Cell Reports, May-2017

National Study Looks at Tobacco Advertising and Susceptibility to Use Tobacco Among Youth

Among 12- to 17-year-olds who have never used tobacco products, nearly half were considered receptive to tobacco marketing if they were able to recall or liked at least one advertisement, report researchers at University of California San Diego Moore...

– University of California San Diego Health


Embargo expired on 22-May-2017 at 00:05 ET

New Bladder Cancer Drug, Skin Cancer Facts, Advanced Stage Colorectal Cancer, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

– Newswise

The Secret to Combating Pancreatic Cancer May Lie in Suppression of a Common Protein

Research from the Keck School of Medicine of USC indicates that in mice with a KRAS mutation, which is present in 90 percent of pancreatic cancer patients, expressing only half the amount of the glucose-regulated protein GRP78 is enough to halt the ...

– Keck Medicine of USC

PNAS May 2017; R21 CA179273; R01 CA027607; R01 CA133117; P30 CA014089; P30 DK048522

NYU Lutheran Experts Use Robotic Surgery to Successfully Treat Kidney Cancer

Incidental discovery of a kidney tumor in a chest scan leads to robotic surgery for kidney cancer.

– NYU Lutheran Medical Center

Rush Clinical Trial Provides New Kidney Cancer Immunotherapy Option

A new clinical trial provides a new option for kidney cancer patients and adds to Rush’s wider research efforts towards identifying immune system biomarkers to better predict which immunotherapy will work best for individuals no matter which cancer...

– Rush University Medical Center

Rare Genetic Defect May Lead to Cancer Drug

Dr. Ayelet Erez, a doctor and geneticist at the Weizmann Institute of Science, has found that while a lack of the protein citrin slows children’s growth, blocking it in cancer slows tumor growth

– Weizmann Institute of Science

Know the Facts About Skin Cancer

One of the most common types of cancer is skin cancer. A UAB dermatologist shares background information, risks and how to protect your skin.

Expert Available

– University of Alabama at Birmingham

Exploring New Treatment Options for Pediatric Patients with Hodgkin Lymphoma

While gemcitabine and brentuximab vedotin each have benefit when given individually in the treatment of Hodgkin lymphoma, Investigators from the Children’s Oncology Group including a Rutgers Cancer Institute of New Jersey physician-scientist examin...

– Rutgers Cancer Institute of New Jersey

American Society of Clinical Oncology Annual Meeting, June-2017

Embargo expired on 17-May-2017 at 17:00 ET

Eating Right and Exercising Could Reduce the Risk of Colon Cancer Recurrence

Colon cancer patients who have a healthy body weight, exercise regularly and eat a diet high in whole grains, fruits and vegetables have a significantly lower risk of cancer recurrence or death, according to a research team led by UC San Francisco in...

– UCSF Helen Diller Family Comprehensive Cancer Center

American Society of Clinical Oncology; NIH U10CA180821, U10CA180882, U10CA180820, KO7CA197077, R01CA118553, P50CA127003, R35CA197735

Embargo expired on 17-May-2017 at 17:00 ET

Polymerases Pause to Help Mediate the Flow of Genetic Information

Stop-and-go traffic is typically a source of frustration, an unneccesary hold-up on the path from point A to point B. But when it comes to the molecular machinery that copies our DNA into RNA, a stop right at the beginning of the path may actually be...

– Stowers Institute for Medical Research

Nature Genetics

Social Contagion in the Exam Room: Peer Influence and Cancer Surgeons’ Use of Breast MRI

A new study by researchers at Yale School of Medicine and Johns Hopkins School of Medicine has found that surgeons’ use of a new imaging test is influenced by the practice style of their peers.

– Yale Cancer Center

Clinical Trials in Need of Diversity in Connecticut

African Americans and other minorities are at a higher risk for certain types of cancer, yet they continue to be underrepresented in clinical trials for drugs approved by the U.S. Food and Drug Administration.

– Yale Cancer Center

Breast Cancer Treatment Costs Higher for Younger Women

Younger women may face higher costs for breast cancer care than older patients at least in part because they're diagnosed when tumors are more advanced and require more aggressive treatment, a recent U.S. study suggests.

– Yale Cancer Center

Brigatinib First Drug to Offer Over 1-Year Control of ALK-Positive Lung Cancer Post-Crizotinib

FDA approves brigatinib as a second-line therapy for ALK-positive non-small cell lung cancer

– University of Colorado Cancer Center

Journal of Clinical Oncology

Researchers Harness Metabolism to Reverse Aggressiveness in Leukemia

Researchers have identified a new drug target for the two most common types of myeloid leukemia, including a way to turn back the most aggressive form of the disease.

– University of Georgia


Early MRI May Lower Costs for Prostate Cancer Treatment

A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical...

– Case Western Reserve University

Radiology, May-2017; KL2TR000440

New Clinical Trial Framework Tests ‘Natural’ Cures for Cancer

A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to test the ability of grape seed extract to slow the rise of prostate-specific antigen (PSA), a comm...

– University of Colorado Cancer Center

Carcinogenesis; Molecular Carcinogenesis; Current Cancer Drug Targets

Sick Kids Live Longer, but Brain Function May Suffer

Hundreds of thousands of children with chronic illnesses who used to die are now surviving their disease and treatment—which is amazing. But their brains are being damaged in the process of keeping them alive. This first ever research quantifies th...

– Vanderbilt University

American Psychologist

Work by Sanford Health Researcher Published Nationally

Paper on immunotherapy for head and neck cancer reports favorable results.

– Sanford Health

Journal of Clinical Oncology


Second Drug Receives FDA Approval for Bladder Cancer Based on Research Led by NYU Langone

The U.S. Food and Drug Administration has granted accelerated approval to a second drug in less than a month for first-line treatment for advanced bladder cancer – again based on clinical trial findings from the same researcher from NYU Langone’s...

– NYU Langone Medical Center

NCCN and Pfizer Address Quality Improvement in Breast Cancer through Clinical Pathways

NCCN and Pfizer seek grant proposals for use of clinical care pathways aimed at quality improvement along the continuum of care for patients with breast cancer.

– National Comprehensive Cancer Network® (NCCN®)

American Academy of Dermatology Statement on the Safety of Sunscreen

The American Academy of Dermatology wants to emphasize that sunscreen remains a safe, effective form of sun protection. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including me...

– American Academy of Dermatology

Moffitt Cancer Center Jumps to No. 4 on 2017 DiversityInc Top Hospitals and Health Systems List

Moffitt Cancer Center moved up two spots to be the No. 4 ranked health care facility on DiversityInc’s 2017 Top Hospitals & Health Systems list. Moffitt is the only cancer center and the only Florida health institution on the specialty list. Diver...

– Moffitt Cancer Center

Department of Energy Secretary Recognizes Argonne Scientists’ Work to Fight Ebola, Cancer

Two groups of researchers at Argonne earned special awards from the office of the U.S. Secretary of Energy for addressing the global health challenges of Ebola and cancer.

– Argonne National Laboratory

Rush Collaborates with Tech Firm Tempus to Expand Cancer Biorepository

Rush has partnered with tech company Tempus to expand its biorepository of tissue samples from cancer patients in order to advance cancer care.

– Rush University Medical Center

Tulane Team Wins Prestigious International Business Model Competition

An interdisciplinary team from Tulane University’s bioinnovation and biomedical engineering departments has won the International Business Model Competition (IBMC) in Mountain View, California.

– Tulane University

Higher Education Events

ASTRO’s 59th Annual Meeting Will Explore the Art and Science of Radiation Oncology

Registration opens today for the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which will highlight advances in cancer research and clinical care involving radiation therapy, also known as radiotherapy.

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2017





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:


 Vanderbilt University

 University of Georgia

 University of California San Diego Health

 University of Alabama at Birmingham

 University of Birmingham

Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us